Market Overview:
The global bisoprolol market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of hypertension, coronary heart disease, and angina pectoris. Additionally, the growing awareness about the benefits of bisoprolol is also contributing to the growth of this market.
Product Definition:
Bisoprolol is a beta blocker medication used to treat high blood pressure, heart failure, and chest pain. It works by blocking the effects of certain hormones that cause blood vessels to constrict.
Tablet Bisoprolol:
Bisoprolol is a beta-blocker drug which works by decreasing the amount of oxygen consumed by the body during cardiac contractions. It's main application is to treat conditions such as atrial fibrillation and heart failure. The tablet form of bisoprolol has been approved for sale in Canada, but it can only be used off-label due to its restricted use in treating atrial fibrillation.
Capsule Bisoprolol:
Bisoprolol is a beta-blocker drug used for the treatment of hypertension and heart failure. It works by decreasing the amount of blood vessels that are able to constrict, which reduces the workload on heart and lungs. The generic name for bisoprolol is Bisoprolol Fumarate; it is manufactured by numerous pharmaceutical companies including Merck & Co., Inc., Pfizer, Inc., Wockhardt Ltd., Mylan N.V.
Application Insights:
High blood pressure was the largest application segment in 2016 and is expected to continue its dominance over the forecast period. The product has been a life saver for millions of patients suffering from hypertension worldwide. It has been proved as one of the most effective medicines for treating high blood pressure, which remains uncorrected despite medical treatment.
The coronary heart disease segment is also expected to grow at a lucrative rate during the forecast period owing to increasing awareness among people regarding early diagnosis and effective treatment procedures. Bisoprolol is an excellent choice for patients with recent history of cardiac arrest or arrhythmia, heart valve problems, stroke or diabetes complications, who have suffered from chest pain or shortness of breath within 48 hours before coming under investigation by doctors.
Regional Analysis:
North America dominated the global market in 2017. High adoption of innovative drugs, favorable government initiatives, and high healthcare expenditure are some of the major factors responsible for its large share. Moreover, increasing awareness about various treatment options is expected to fuel the regional market over the forecast period.
Asia Pacific is anticipated to be one of the fastest-growing regions during the forecast period owing to rising disposable income and improving healthcare infrastructure in emerging countries such as China and India. Furthermore, an increase in Bisoprolol tablets consumption due to growing target population base will drive growth further.
Growth Factors:
- Increasing prevalence of hypertension and other heart diseases: The global prevalence of hypertension is estimated to be around 1.13 billion in 2015 and is projected to reach 1.56 billion by 2025. This will create a large pool of patients who will require treatment, thereby driving the demand for bisoprolol products.
- Rising geriatric population: The global geriatric population (aged 65 years or above) is expected to grow from 524 million in 2010 to nearly 1.5 billion by 2050, creating a large pool of patients with cardiovascular diseases that will need treatment with bisoprolol products.
Scope Of The Report
Report Attributes
Report Details
Report Title
Bisoprolol Market Research Report
By Type
Tablet Bisoprolol, Capsule Bisoprolol
By Application
High Blood Pressure(Hypertension), Coronary Heart Disease, Angina Pectoris, Others
By Companies
Hexal(Novartis), Merck, Teva Pharmaceuticals, Medreich, VHB Lifesciences, Shrrishti Healthcare Products, Intas Pharmaceutical, Rusan Healthcare, Vidakem Lifesciences, US Vitamins, Hexal(Novartis), Yangtze River Pharmaceutical Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
180
Number of Tables & Figures
126
Customization Available
Yes, the report can be customized as per your need.
Global Bisoprolol Market Report Segments:
The global Bisoprolol market is segmented on the basis of:
Types
Tablet Bisoprolol, Capsule Bisoprolol
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
High Blood Pressure(Hypertension), Coronary Heart Disease, Angina Pectoris, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Hexal(Novartis)
- Merck
- Teva Pharmaceuticals
- Medreich
- VHB Lifesciences
- Shrrishti Healthcare Products
- Intas Pharmaceutical
- Rusan Healthcare
- Vidakem Lifesciences
- US Vitamins
- Hexal(Novartis)
- Yangtze River Pharmaceutical Group
Highlights of The Bisoprolol Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablet Bisoprolol
- Capsule Bisoprolol
- By Application:
- High Blood Pressure(Hypertension)
- Coronary Heart Disease
- Angina Pectoris
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bisoprolol Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bisoprolol is a beta blocker medication that is used to treat hypertension (high blood pressure). It works by blocking the action of adrenaline and other hormones that cause the heart to beat faster.
Some of the key players operating in the bisoprolol market are Hexal(Novartis), Merck, Teva Pharmaceuticals, Medreich, VHB Lifesciences, Shrrishti Healthcare Products, Intas Pharmaceutical, Rusan Healthcare, Vidakem Lifesciences, US Vitamins, Hexal(Novartis), Yangtze River Pharmaceutical Group.
The bisoprolol market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bisoprolol Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bisoprolol Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bisoprolol Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bisoprolol Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bisoprolol Market Size & Forecast, 2020-2028
4.5.1 Bisoprolol Market Size and Y-o-Y Growth
4.5.2 Bisoprolol Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Tablet Bisoprolol
5.2.2 Capsule Bisoprolol
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 High Blood Pressure(Hypertension)
6.2.2 Coronary Heart Disease
6.2.3 Angina Pectoris
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bisoprolol Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bisoprolol Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Tablet Bisoprolol
9.6.2 Capsule Bisoprolol
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 High Blood Pressure(Hypertension)
9.10.2 Coronary Heart Disease
9.10.3 Angina Pectoris
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Tablet Bisoprolol
10.6.2 Capsule Bisoprolol
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 High Blood Pressure(Hypertension)
10.10.2 Coronary Heart Disease
10.10.3 Angina Pectoris
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Tablet Bisoprolol
11.6.2 Capsule Bisoprolol
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 High Blood Pressure(Hypertension)
11.10.2 Coronary Heart Disease
11.10.3 Angina Pectoris
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Tablet Bisoprolol
12.6.2 Capsule Bisoprolol
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 High Blood Pressure(Hypertension)
12.10.2 Coronary Heart Disease
12.10.3 Angina Pectoris
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Tablet Bisoprolol
13.6.2 Capsule Bisoprolol
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 High Blood Pressure(Hypertension)
13.10.2 Coronary Heart Disease
13.10.3 Angina Pectoris
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bisoprolol Market: Competitive Dashboard
14.2 Global Bisoprolol Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Hexal(Novartis)
14.3.2 Merck
14.3.3 Teva Pharmaceuticals
14.3.4 Medreich
14.3.5 VHB Lifesciences
14.3.6 Shrrishti Healthcare Products
14.3.7 Intas Pharmaceutical
14.3.8 Rusan Healthcare
14.3.9 Vidakem Lifesciences
14.3.10 US Vitamins
14.3.11 Hexal(Novartis)
14.3.12 Yangtze River Pharmaceutical Group
